AbbVie Inc. (ABBV) vs Vanguard Total Bond Market Index Fund (BND)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Vanguard Total Bond Market ETF is an exchange-traded fund focused on the broad U.S. investment-grade bond market. It provides access to a diversified portfolio of fixed-income securities and is commonly used for income generation, liquidity management, or duration positioning. Its performance is influenced by interest-rate changes, credit spreads, issuer quality, maturity profile, reinvestment yields, and fund expenses. Bond ETFs can still fluctuate in value, especially when rates or credit conditions move quickly.